-
Update21 June 2022
The Global Fund Joins Partners in Committing to Address Large Shortfalls in Oxygen
-
Update13 June 2022
Opportunity for Evaluation of Diagnostic Products – Syphilis Diagnosis
-
Update20 May 2022
External Quality Assessment: Highest Possible Results for OIG Audit and Investigation Units
-
Update20 May 2022
New Isoniazid/rifapentine and rifapentine generic for tuberculosis (TB) prevention recently recommended for use by ERP
-
Update03 May 2022
Global Fund Appoints Susie Rhee as General Counsel and Head of the Legal & Governance Department
-
Update08 April 2022
Opportunity for Evaluation of Diagnostic Products
-
Update08 April 2022
Message from the Executive Director: Global Fund Grants in Liberia
-
Update08 April 2022
Liberia: Fraudulent and Abusive Practices in Global Fund Programs
-
Update06 April 2022
Message from the Executive Director: Global Fund Grants in Nigeria
-
Event05 April 2022
Virtual Press Briefing: A Strategy to Manage Long-Term Risks of COVID-19
-
Update30 March 2022
Audit of the COVID-19 Response Mechanism 2021
-
Update28 March 2022
Data Science Catalytic Fund - Improving Collection and Use of Community Health Data